A Phase 1, 3-Part, Single Ascending Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Lu AG22515 (APB-A1) in Healthy Adult Subjects
The main goal of this study is to learn more about the safety of a drug called Lu AG22515. During the trial, healthy adult participants will receive a single dose of Lu AG22515 or a placebo (normal saline solution).
100 项与 Lu-AG22515 相关的临床结果
100 项与 Lu-AG22515 相关的转化医学
100 项与 Lu-AG22515 相关的专利(医药)
100 项与 Lu-AG22515 相关的药物交易